Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective and Neuro-restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson’s Disease
Aileen Cronin, Maura Grealy
Neuroscience (2017) Vol. 367, pp. 34-46
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

The therapeutic role of minocycline in Parkinson’s disease
Şeyda Çankaya, Barış Çankaya, Ülkan Kılıç, et al.
Drugs in Context (2019) Vol. 8, pp. 1-14
Open Access | Times Cited: 86
Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery
Xiaobo Wang, Jinbao Zhang, Kaijie He, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 76
Minocycline in neurodegenerative and psychiatric diseases: An update
Diego Romero‐Miguel, Nicolás Lamanna‐Rama, Marta Casquero‐Veiga, et al.
European Journal of Neurology (2020) Vol. 28, Iss. 3, pp. 1056-1081
Open Access | Times Cited: 70
Zebrafish as a model organism for neurodegenerative disease
Kelda Chia, Anna Klingseisen, Dirk Sieger, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 65
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12289-12289
Open Access | Times Cited: 46
Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
Shuanglong Yi, Linfang Wang, Honglei Wang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14753-14753
Open Access | Times Cited: 41
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
Iván Carrera, Ramón Cacabelos
Current Neuropharmacology (2018) Vol. 17, Iss. 3, pp. 295-306
Open Access | Times Cited: 67
Zebrafish: A Promising Model for Evaluating the Toxicity of Carbon Dot-Based Nanomaterials
Wei Liu, Gang Huang, Xiaoying Su, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 43, pp. 49012-49020
Closed Access | Times Cited: 58
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo
Antonio Dominguez‐Meijide, Valeria Parrales, Eftychia Vasili, et al.
Neurobiology of Disease (2021) Vol. 151, pp. 105256-105256
Open Access | Times Cited: 55
Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson’s disease
Dingyi Yu, Pengli Zhang, Junying Li, et al.
Journal of Pharmaceutical Analysis (2020) Vol. 11, Iss. 2, pp. 220-231
Open Access | Times Cited: 52
Zebrafish and Medaka: Important Animal Models for Human Neurodegenerative Diseases
Jing Wang, Hong Cao
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10766-10766
Open Access | Times Cited: 43
Activation of Atg7-dependent autophagy by a novel inhibitor of the Keap1–Nrf2 protein–protein interaction from Penthorum chinense Pursh. attenuates 6-hydroxydopamine-induced ferroptosis in zebrafish and dopaminergic neurons
Yiran Sun, Libo He, Wang Wang, et al.
Food & Function (2022) Vol. 13, Iss. 14, pp. 7885-7900
Closed Access | Times Cited: 35
Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
Makoto Naoi, Wakako Maruyama, Masayo Shamoto‐Nagai
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11059-11059
Open Access | Times Cited: 34
The neuroprotective effect of schisandrol A on 6-OHDA-induced PD mice may be related to PI3K/AKT and IKK/IκBα/NF-κB pathway
Tingxu Yan, Yingying Sun, Guowei Gong, et al.
Experimental Gerontology (2019) Vol. 128, pp. 110743-110743
Closed Access | Times Cited: 52
Anti-Inflammation Associated Protective Mechanism of Berberine and its Derivatives on Attenuating Pentylenetetrazole-Induced Seizures in Zebrafish
Baoyue Zhang, Lizhen Wang, Xiuna Ji, et al.
Journal of Neuroimmune Pharmacology (2020) Vol. 15, Iss. 2, pp. 309-325
Closed Access | Times Cited: 47
Parkinson’s Disease-Induced Zebrafish Models: Focussing on Oxidative Stress Implications and Sleep Processes
Madalina Andreea Robea, Ioana-Miruna Balmuș, Alin Ciobîcă, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 47
Machine learning discriminates a movement disorder in a zebrafish model of Parkinson's disease
Gideon L. Hughes, Michael A. Lones, Matthew Bedder, et al.
Disease Models & Mechanisms (2020) Vol. 13, Iss. 10
Open Access | Times Cited: 44
Boosting mitochondrial health to counteract neurodegeneration
Johannes Burtscher, Mario Romani, Greta Bernardo, et al.
Progress in Neurobiology (2022) Vol. 215, pp. 102289-102289
Open Access | Times Cited: 23
Combined effects of lead and manganese on locomotor activity and microbiota in zebrafish
Yuan Xia, Chunyu Wang, Xiaoshun Zhang, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 263, pp. 115260-115260
Open Access | Times Cited: 16
Effects of ecologically relevant concentrations of cadmium on locomotor activity and microbiota in zebrafish
Yuan Xia, Jiawei Zhu, Yongjie Xu, et al.
Chemosphere (2020) Vol. 257, pp. 127220-127220
Closed Access | Times Cited: 39
Treatment of Parkinson's disease in Zebrafish model with a berberine derivative capable of crossing blood brain barrier, targeting mitochondria, and convenient for bioimaging experiments
Lizhen Wang, Wenlong Sheng, Zhaoshun Tan, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2021) Vol. 249, pp. 109151-109151
Closed Access | Times Cited: 27
Zebrafish, Medaka and Turquoise Killifish for Understanding Human Neurodegenerative/Neurodevelopmental Disorders
Kazuki Kodera, Hideaki Matsui
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1399-1399
Open Access | Times Cited: 21
Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease
Victoria Chaoul, Emanuel‐Youssef Dib, Joe Bedran, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14898-14898
Open Access | Times Cited: 12
Experimental models of chemically induced Parkinson’s disease in zebrafish at the embryonic larval stage: a systematic review
Paola Briñez-Gallego, Dennis Guilherme da Costa Silva, Marcos Freitas Cordeiro, et al.
Journal of Toxicology and Environmental Health Part B (2023) Vol. 26, Iss. 4, pp. 201-237
Closed Access | Times Cited: 11
Neuroprotective Kunitz-like peptides identified from the octopus coral Galaxea fascicularis through transcriptomic analysis
Hanbin Chen, Hiotong Kam, Shirley W. I. Siu, et al.
Water Biology and Security (2025), pp. 100358-100358
Open Access
Page 1 - Next Page

Scroll to top